Literature DB >> 29572558

Modulation of sodium channels as pharmacological tool for pain therapy-highlights and gaps.

Nilufar Foadi1.   

Abstract

Voltage-gated sodium channels are crucially involved in the transduction and transmission of nociceptive signals and pathological pain states. In the past decades, a lot of effort has been spent examining and characterizing biophysical properties of the different sodium channels and their role in signaling pathways. Several gains of function mutations of the sodium channels Nav1.7, Nav1.8, and Nav1.9 are associated with pain disorders. Due to their critical role in nociceptive pathways voltage-gated sodium channels are regarded interesting targets for pharmacological pain treatment. However we still need to fill the gap that exists in the translation of efficacy in preclinical in vitro experiments and in models of pain into the clinic. This review summarizes biological and electrophysiological properties of voltage-gated sodium channels and aims to discuss limitations and promising pharmacological strategies in sodium channel research in the context of pain therapy.

Entities:  

Keywords:  Analgesia; Pain signaling pathways; Translational research; Voltage-gated sodium channel

Mesh:

Substances:

Year:  2018        PMID: 29572558     DOI: 10.1007/s00210-018-1487-3

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  87 in total

1.  Nav1.7, its mutations, and the syndromes that they cause.

Authors:  Stephen G Waxman
Journal:  Neurology       Date:  2007-08-07       Impact factor: 9.910

2.  Amitriptyline for prolonged cutaneous analgesia in the rat.

Authors:  Mohammed A Khan; Peter Gerner; Ging Kuo Wang
Journal:  Anesthesiology       Date:  2002-01       Impact factor: 7.892

3.  On the simple random-walk models of ion-channel gate dynamics reflecting long-term memory.

Authors:  Agata Wawrzkiewicz; Krzysztof Pawelek; Przemyslaw Borys; Beata Dworakowska; Zbigniew J Grzywna
Journal:  Eur Biophys J       Date:  2012-04-07       Impact factor: 1.733

4.  Intrathecal miR-96 inhibits Nav1.3 expression and alleviates neuropathic pain in rat following chronic construction injury.

Authors:  Hong-Ping Chen; Wei Zhou; Lu-Mei Kang; Han Yan; Lei Zhang; Bao-Hua Xu; Wei-Hua Cai
Journal:  Neurochem Res       Date:  2014-01       Impact factor: 3.996

Review 5.  NaV1.9: a sodium channel linked to human pain.

Authors:  Sulayman D Dib-Hajj; Joel A Black; Stephen G Waxman
Journal:  Nat Rev Neurosci       Date:  2015-08-05       Impact factor: 34.870

6.  Evaluation of the effect of locally administered amitriptyline gel as adjunct to local anesthetics in irreversible pulpitis pain.

Authors:  A A Moghadamnia; M Partovi; I Mohammadianfar; Z Madani; E Zabihi; M R Hamidi; M Baradaran
Journal:  Indian J Dent Res       Date:  2009 Jan-Mar

7.  An SCN9A channelopathy causes congenital inability to experience pain.

Authors:  James J Cox; Frank Reimann; Adeline K Nicholas; Gemma Thornton; Emma Roberts; Kelly Springell; Gulshan Karbani; Hussain Jafri; Jovaria Mannan; Yasmin Raashid; Lihadh Al-Gazali; Henan Hamamy; Enza Maria Valente; Shaun Gorman; Richard Williams; Duncan P McHale; John N Wood; Fiona M Gribble; C Geoffrey Woods
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

8.  Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors.

Authors:  Stuart M Chambers; Yuchen Qi; Yvonne Mica; Gabsang Lee; Xin-Jun Zhang; Lei Niu; James Bilsland; Lishuang Cao; Edward Stevens; Paul Whiting; Song-Hai Shi; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2012-07-01       Impact factor: 54.908

9.  Mechanism of sodium channel NaV1.9 potentiation by G-protein signaling.

Authors:  Carlos G Vanoye; Jennifer D Kunic; George R Ehring; Alfred L George
Journal:  J Gen Physiol       Date:  2013-02       Impact factor: 4.086

Review 10.  Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief.

Authors:  Edward C Emery; Ana Paula Luiz; John N Wood
Journal:  Expert Opin Ther Targets       Date:  2016-04-12       Impact factor: 6.902

View more
  1 in total

Review 1.  Mining the Nav1.7 interactome: Opportunities for chronic pain therapeutics.

Authors:  Lindsey A Chew; Shreya S Bellampalli; Erik T Dustrude; Rajesh Khanna
Journal:  Biochem Pharmacol       Date:  2019-01-27       Impact factor: 5.858

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.